Skip to main navigation Skip to search Skip to main content

Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of olanzapine on endogenous glucose production.

  • E.M. Girault
  • , E. Foppen
  • , M.T. Ackermans
  • , E. Fliers
  • , A. Kalsbeek

Research output: Contribution to journal/periodicalArticleScientificpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)238-245
JournalBrain Research
Volume1527
DOIs
Publication statusPublished - 2013

Cite this